
Targets Conference Showcases Exciting Data from Clinical Trials of Innovative Cancer Therapeutics
There has been an explosion in the number of cancer therapeutics and clinical trials in the recent past, owing...
Home »
There has been an explosion in the number of cancer therapeutics and clinical trials in the recent past, owing...
After three decades of failed efforts to target the elusive KRAS and its family members NRAS and HRAS, proto-oncogenes...
The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held this year at the Hynes Convention Center in...